Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations
The introduction of Direct Oral Anticoagulants (DOACs) to the pharmaceutical market provided patients and clinicians with novel convenient and safe options of anticoagulation. The use of this class of medications is currently limited to venous thromboembolic therapy and prophylaxis, in addition to s...
| Published in: | Canadian Journal of Gastroenterology and Hepatology |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Online Access: | http://dx.doi.org/10.1155/2019/4383269 |